Gf Fund Management Co., Ltd. - CSI Hong Kong Brand Name Drug Index ETF (SHA:513120)
1.582
+0.081 (5.40%)
At close: Sep 5, 2025
SHA:513120 Holdings Information
SHA:513120 is an equity ETF with a total of 40 individual holdings. The top holdings are Innovent Biologics stock at 9.70%, WuXi Biologics at 9.69%, BeOne Medicines AG at 8.99%, Akeso at 7.70%, and CSPC Pharmaceutical Group at 7.28%.
Total Holdings
40
Top 10 Percentage
67.02%
Asset Class
Equity
ETF Category
Health Care
Assets
n/a
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | HKG: 1801 | Innovent Biologics, Inc. | 9.70% |
2 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 9.69% |
3 | HKG: 6160 | BeOne Medicines AG | 8.99% |
4 | HKG: 9926 | Akeso, Inc. | 7.70% |
5 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 7.28% |
6 | HKG: 1177 | Sino Biopharmaceutical Limited | 6.93% |
7 | HKG: 1530 | 3SBio Inc. | 5.28% |
8 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 4.13% |
9 | n/a | Cash | 3.74% |
10 | HKG: 9688 | Zai Lab Limited | 3.58% |
11 | WUXIF | WuXi AppTec Co., Ltd. | 3.53% |
12 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 3.05% |
13 | HKG: 1548 | Genscript Biotech Corporation | 2.66% |
14 | HKG: 9969 | InnoCare Pharma Limited | 2.28% |
15 | HKG: 6855 | Ascentage Pharma Group International | 2.19% |
16 | HKG: 0867 | China Medical System Holdings Limited | 2.04% |
17 | 13.HK | HUTCHMED (China) Ltd | 1.69% |
18 | HKG: 1952 | Everest Medicines Limited | 1.63% |
19 | HKG: 0512 | Grand Pharmaceutical Group Limited | 1.46% |
20 | REGMF | RemeGen Co Ltd Class H | 1.31% |
21 | HKG: 2268 | WuXi XDC Cayman Inc. | 1.15% |
22 | HKG: 2186 | Luye Pharma Group Ltd. | 1.10% |
23 | HKG: 2228 | XtalPi Holdings Limited | 1.09% |
24 | HKG: 2162 | Keymed Biosciences Inc. | 1.08% |
25 | SFOSF | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1.06% |
As of Jun 30, 2025